AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-14396_ITM" title="Facts and information about Combination HT Therapy. (Hypertension).">Combination HT Therapy. (Hypertension).</a>
Close
Set up an RSS feed that alerts you when new articles from OB GYN News are available.
Frequently asked questions about RSS feeds
Combination HT Therapy. (Hypertension).
The combination of an angiotensin receptor blocker plus hydrochiorothiazide is a more cost-effective treatment for hypertension than an angiotensin receptor blocker alone, Daniel E. Hilleman, Pharm.D., said in a poster presentation at the annual meeting of the American Society of Hypertension.
Investigators analyzed data on 3,883 patients from 14 randomized, controlled trials that evaluated three commercially available fixed-dose combinations of hydrochiorothiazide and an angiotensin receptor blocker (ARB)--losartan, telmisartan, or valsartan, They calculated costeffectiveness using annual average wholesale prices and pooled estimates of blood pressure reductions.
Combining ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- New angiotensin receptor blocker is as effective as ACE inhibitor.(News)
- Magazine article from: British Medical Journal Gottlieb, Scott November 15, 2003 700+ words
An angiotensin receptor blocker is as effective as an angiotensin...compared the effect of the angiotensin receptor blocker valsartan, the ACE inhibitor...with the addition of an angiotensin receptor blocker to conventional treatment...
- Study finds major new uses for ARBs in symptomatic heart failure patients:...
- Magazine article from: Family Practice News Jancin, Bruce October 1, 2003 700+ words
VIENNA -- The angiotensin receptor blocker candesartan provides clinical...CHF) population in whom angiotensin receptor blockade is beneficial...ever clinical trial of an angiotensin receptor blocker (ARB) in CHF. The program...
- Angiotensin receptor blocker adherence appears to be good. (Less Switching of...
- Magazine article from: Family Practice News Jancin, Bruce November 15, 2002 700+ words
BERLIN -- Patient adherence to angiotensin receptor blocker therapy appears to be greater than for other...829 a [beta]-blocker, and 2,018 an angiotensin receptor blocker (ARB). The mean age of patients was similar...
- Angiotensin receptor blocker cuts atrial fibrillation: Val-HeFT and life...
- Magazine article from: Family Practice News Jancin, Bruce February 1, 2004 700+ words
VIENNA -- Angiotensin receptor blocker therapy reduces the incidence of new-onset atrial fibrillation...and human data suggest that the AF-preventing effect of angiotensin receptor blocker therapy in these patients is not purely a hemodynamic one...
- Aliskiren, the First Effective Oral Renin Inhibitor, Provides Sustained 24 Hour...
- Press release article from: PR Newswire November 15, 2005 700+ words
...pressure (BP) by combining aliskiren with an angiotensin receptor blocker. Results of the 9-week clinical study show...monitoring) when added to irbesartan, an angiotensin receptor blocker (ARB) (p<0.05). In addition to...
- Atacand.(angiotensin receptor blocker )(Brief Article)
- Magazine article from: Internal Medicine News Mechcatie, Elizabeth June 15, 2005 700+ words
Atacand (candesartan, AstraZeneca) The approval of the angiotensin receptor blocker (ARB)--to reduce cardiovascular death and heart failure hospitalizations in patients with heart failure (NYHA II-IV and...
- FIRST JAPANESE INTERVENTION ANGIOTENSIN RECEPTOR BLOCKER TRIAL.
- News wire article from: AsiaPulse News April 27, 2007 700+ words
(Full text of a statement. Contact details below.) First Controlled Large-Scale Intervention Angiotensin Receptor Blocker (ARB) Trial in a Japanese Population TOKYO, April 27 /Xinhua-PRNewswire-AsiaNet/ -- JIKEI HEART...
- JournalWatch: ARB best for diabetes risk.(Angiotensin receptor blocker)(Brief...
- Newspaper article from: Pulse July 6, 2006 700+ words
High-risk hypertensive patients have a lower risk of diabetes on a angiotensin receptor blocker than on a calcium channel blocker, the international Value trial reports. The researchers compared use of valsartan and amlodipine...
- ACE inhibitor/ARB combination does more harm than good.(Cardiovascular...
- Magazine article from: Family Practice News May 1, 2008 700+ words
...American College of Cardiology. ONTARGET was designed to answer two clinically relevant questions: Is the angiotensin-receptor blocker (ARB) telmisartan an effective alternative to ramipril in the 20%-30% of patients who can't tolerate...
- Landmark Study Shows ATACAND(R) Reduces Risk of Cardiovascular Death In...
- Press release article from: PR Newswire September 2, 2003 700+ words
In the most comprehensive trial program to date with an angiotensin receptor blocker (ARB) for heart failure, AstraZeneca's ATACAND(R) (candesartan cilexetil), has been shown to improve survival in patients...
Source: HighBeam Research, Combination HT Therapy. (Hypertension).